Thomas Stephan
Stock Analyst at Stifel
(2.36)
# 2,526
Out of 4,761 analysts
39
Total ratings
51.85%
Success rate
-1.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Buy | $6 → $5 | $2.53 | +97.63% | 6 | Feb 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.75 | +14.29% | 3 | Jan 29, 2025 | |
| RXST RxSight | Maintains: Hold | $40 → $35 | $29.60 | +18.24% | 8 | Jan 13, 2025 | |
| GKOS Glaukos | Maintains: Buy | $153 → $175 | $125.88 | +39.02% | 8 | Dec 31, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 → $44 | $16.87 | +160.82% | 8 | Aug 26, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.51 | +32.89% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $90.31 | +10.73% | 4 | May 15, 2024 |
Sight Sciences
Feb 6, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $2.53
Upside: +97.63%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.75
Upside: +14.29%
RxSight
Jan 13, 2025
Maintains: Hold
Price Target: $40 → $35
Current: $29.60
Upside: +18.24%
Glaukos
Dec 31, 2024
Maintains: Buy
Price Target: $153 → $175
Current: $125.88
Upside: +39.02%
STAAR Surgical Company
Aug 26, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $16.87
Upside: +160.82%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.51
Upside: +32.89%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $90.31
Upside: +10.73%